Subscribe To
Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
Auvelity® 1Q 2023 net product sales of $15.7 million Total 1Q 2023 net product sales of $28.6 million Total 1Q 2023 revenue of $94.6 million, including Sunosi® ex-U.S. license agreement upfront payment Company to host conference call today at 8:00 AM Eastern NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), […] The post Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update appeared first on ForexTV...
Read More
Posted: May 8 2023, 11:00
Author Name: forextv
Views: 081895